Target : €0.85
Comment:
News are good, we need volume !
- NOVACYT 1.12% launches the first of a series of new products in infectious diseases
- NOVACYT 1.12% Receives €4 Million Loan Facility for Mergers & Acquisitions
- NOVACYT 1.12% growth reached 35% in 2017
Comment:
The target has been reassessed at $90.
